Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Were thrilled to bring a longevity-focused version of our Noom behavior program to members interested in proactively improving their health
Intended Use: For Laboratory Research Use Only Key Characteristics of Tirzepatide (50 mg) Dual incretin receptor-targeted peptide for metabolic research Designed to activate both GIP and GLP-1 receptors in controlled experimental models C20 fatty acid side-chain modification supports enhanced molecular stability and prolonged receptor interaction Amino acid substitutions increase resistance to enzymatic degradation High purity confirmed through HPLC and mass spectrometry Lyophilized form preserves structural integrity before reconstitution Ideal for in vitro studies and preclinical metabolic research models How Tirzepatide (50 mg) Supports Research Tirzepatide (50 mg) is used in laboratory experiments to study the dual activation of GIP and GLP-1 receptors
Waist circumference decreases by 4 to 8 inches on average
This creates a double safety barrier
Doctors often choose FDA-approved options from reliable manufacturers like Novo Nordisk to ensure their patients get quality and safe medication
